492 related articles for article (PubMed ID: 20124634)
1. [AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era].
Zucchetto A; Bruzzone S; De Paoli A; Regine V; Pappagallo M; Dal Maso L; Serraino D; Rezza G; Suligoi B
Epidemiol Prev; 2009; 33(4-5):184-9. PubMed ID: 20124634
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for early mortality after AIDS in the cART era: A population-based cohort study in Italy.
Suligoi B; Zucchetto A; Grande E; Camoni L; Dal Maso L; Frova L; Virdone S; Boros S; Pappagallo M; Taborelli M; Regine V; De Paoli P; Serraino D
BMC Infect Dis; 2015 Jun; 15():229. PubMed ID: 26067992
[TBL] [Abstract][Full Text] [Related]
3. Differential impact of combined antiretroviral therapy on the survival of italian patients with specific AIDS-defining illnesses.
Conti S; Masocco M; Pezzotti P; Toccaceli V; Vichi M; Boros S; Urciuoli R; Valdarchi C; Rezza G
J Acquir Immune Defic Syndr; 2000 Dec; 25(5):451-8. PubMed ID: 11141245
[TBL] [Abstract][Full Text] [Related]
4. Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons--San Francisco, 1981-2012.
Djawe K; Buchacz K; Hsu L; Chen MJ; Selik RM; Rose C; Williams T; Brooks JT; Schwarcz S
J Infect Dis; 2015 Nov; 212(9):1366-75. PubMed ID: 26044289
[TBL] [Abstract][Full Text] [Related]
5. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
[TBL] [Abstract][Full Text] [Related]
6. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
[TBL] [Abstract][Full Text] [Related]
7. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
[TBL] [Abstract][Full Text] [Related]
8. Determinants of progression to AIDS and death following HIV diagnosis: a retrospective cohort study in Wuhan, China.
Jiang H; Xie N; Cao B; Tan L; Fan Y; Zhang F; Yao Z; Liu L; Nie S
PLoS One; 2013; 8(12):e83078. PubMed ID: 24376638
[TBL] [Abstract][Full Text] [Related]
9. Survival after AIDS diagnosis in Italy, 1999-2006: a population-based study.
Serraino D; Zucchetto A; Suligoi B; Bruzzone S; Camoni L; Boros S; De Paoli A; Dal Maso L; Franceschi S; Rezza G
J Acquir Immune Defic Syndr; 2009 Sep; 52(1):99-105. PubMed ID: 19448558
[TBL] [Abstract][Full Text] [Related]
10. Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain.
Rodríguez-Arenas MA; Jarrín I; del Amo J; Iribarren JA; Moreno S; Viciana P; Peña A; Sirvent JL; Vidal F; Lacruz J; Gutierrez F; Oteo JA; Asencio R; Castilla J; Hoyos SP;
AIDS Res Hum Retroviruses; 2006 Aug; 22(8):715-23. PubMed ID: 16910826
[TBL] [Abstract][Full Text] [Related]
11. The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.
Murray M; Hogg RS; Lima VD; May MT; Moore DM; Abgrall S; Bruyand M; D'Arminio Monforte A; Tural C; Gill MJ; Harris RJ; Reiss P; Justice A; Kirk O; Saag M; Smith CJ; Weber R; Rockstroh J; Khaykin P; Sterne JA;
HIV Med; 2012 Feb; 13(2):89-97. PubMed ID: 21819529
[TBL] [Abstract][Full Text] [Related]
12. Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort.
Garriga C; García de Olalla P; Miró JM; Ocaña I; Knobel H; Barberá MJ; Humet V; Domingo P; Gatell JM; Ribera E; Gurguí M; Marco A; Caylà JA;
PLoS One; 2015; 10(12):e0145701. PubMed ID: 26716982
[TBL] [Abstract][Full Text] [Related]
13. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.
; Mocroft A; Sterne JA; Egger M; May M; Grabar S; Furrer H; Sabin C; Fatkenheuer G; Justice A; Reiss P; d'Arminio Monforte A; Gill J; Hogg R; Bonnet F; Kitahata M; Staszewski S; Casabona J; Harris R; Saag M
Clin Infect Dis; 2009 Apr; 48(8):1138-51. PubMed ID: 19275498
[TBL] [Abstract][Full Text] [Related]
14. Trends of AIDS in Guadeloupe (French West Indies) a longitudinal survey from 1988 to 1997.
Deloumeaux J; Foucan L; Sow-Goerger MT; Contamin B; Strobel M
West Indian Med J; 2000 Jun; 49(2):148-53. PubMed ID: 10948855
[TBL] [Abstract][Full Text] [Related]
15. Changes in causes of death among persons with AIDS: San Francisco, California, 1996-2011.
Schwarcz SK; Vu A; Hsu LC; Hessol NA
AIDS Patient Care STDS; 2014 Oct; 28(10):517-23. PubMed ID: 25275657
[TBL] [Abstract][Full Text] [Related]
16. Associated factors for progression to AIDS among HIV-infected people who use drugs: a retrospective cohort study in Dongguan, China.
Luo H; Sun M; Du J
BMJ Open; 2019 Jul; 9(7):e023841. PubMed ID: 31272970
[TBL] [Abstract][Full Text] [Related]
17. Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study.
Larsen MV; Omland LH; Gerstoft J; Larsen CS; Jensen J; Obel N; Kronborg G
Addiction; 2010 Mar; 105(3):529-35. PubMed ID: 20402997
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for the survival of patients with AIDS cholangiopathy.
Ko WF; Cello JP; Rogers SJ; Lecours A
Am J Gastroenterol; 2003 Oct; 98(10):2176-81. PubMed ID: 14572564
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
[TBL] [Abstract][Full Text] [Related]
20. Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
Spillane H; Nicholas S; Tang Z; Szumilin E; Balkan S; Pujades-Rodriguez M
Trop Med Int Health; 2012 Oct; 17(10):1255-63. PubMed ID: 22863110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
